BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 34672766)

  • 21. Nutrient-induced stimulation of protein synthesis in mouse skeletal muscle is limited by the mTORC1 repressor REDD1.
    Gordon BS; Williamson DL; Lang CH; Jefferson LS; Kimball SR
    J Nutr; 2015 Apr; 145(4):708-13. PubMed ID: 25716553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered nutrient response of mTORC1 as a result of changes in REDD1 expression: effect of obesity vs. REDD1 deficiency.
    Williamson DL; Li Z; Tuder RM; Feinstein E; Kimball SR; Dungan CM
    J Appl Physiol (1985); 2014 Aug; 117(3):246-56. PubMed ID: 24876363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diet-induced obesity does not exacerbate cachexia in male mice bearing Lewis-lung carcinoma tumors.
    Beaudry AG; Law ML; Gilley-Connor KR; Buley H; Dungan CM; Nascimento CMC; Vichaya EG; Wiggs MP
    Am J Physiol Regul Integr Comp Physiol; 2024 Mar; 326(3):R254-R265. PubMed ID: 38252513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. β‑carotene attenuates muscle wasting in cancer cachexia by regulating myogenesis and muscle atrophy.
    Kim Y; Oh Y; Kim YS; Shin JH; Lee YS; Kim Y
    Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37975253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness.
    Neyroud D; Nosacka RL; Callaway CS; Trevino JG; Hu H; Judge SM; Judge AR
    J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):421-442. PubMed ID: 33527776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer-Induced Muscle Wasting Requires p38β MAPK Activation of p300.
    Sin TK; Zhang G; Zhang Z; Zhu JZ; Zuo Y; Frost JA; Li M; Li YP
    Cancer Res; 2021 Feb; 81(4):885-897. PubMed ID: 33355181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lewis lung carcinoma regulation of mechanical stretch-induced protein synthesis in cultured myotubes.
    Gao S; Carson JA
    Am J Physiol Cell Physiol; 2016 Jan; 310(1):C66-79. PubMed ID: 26491045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morin suppresses cachexia-induced muscle wasting by binding to ribosomal protein S10 in carcinoma cells.
    Yoshimura T; Saitoh K; Sun L; Wang Y; Taniyama S; Yamaguchi K; Uchida T; Ohkubo T; Higashitani A; Nikawa T; Tachibana K; Hirasaka K
    Biochem Biophys Res Commun; 2018 Dec; 506(4):773-779. PubMed ID: 30389140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrine improves skeletal muscle atrophy by inhibiting E3 ubiquitin ligases and activating the Akt/mTOR/FoxO3α signaling pathway in C2C12 myotubes and mice.
    Chen L; Chen L; Wan L; Huo Y; Huang J; Li J; Lu J; Xin B; Yang Q; Guo C
    Oncol Rep; 2019 Aug; 42(2):479-494. PubMed ID: 31233199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.
    Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y
    Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of S-pindolol in mouse pancreatic and lung cancer cachexia models.
    Springer J; Jové Q; de Lima Junior EA; Ladrón NÁ; López-Soriano FJ; Busquets S; Argiles JM; Marks DL
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1244-1248. PubMed ID: 37130578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute treadmill exercise discriminately improves the skeletal muscle insulin-stimulated growth signaling responses in mice lacking REDD1.
    Dungan CM; Gordon BS; Williamson DL
    Physiol Rep; 2019 Feb; 7(4):e14011. PubMed ID: 30806987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced REDD1 expression contributes to activation of mTORC1 following electrically induced muscle contraction.
    Gordon BS; Steiner JL; Lang CH; Jefferson LS; Kimball SR
    Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E703-11. PubMed ID: 25159324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PGC-1α overexpression is not sufficient to mitigate cancer cachexia in either male or female mice.
    Morena da Silva F; Rosa-Caldwell ME; Schrems ER; Martinez L; Amos MG; Lim S; Cabrera AR; Brown JL; Washington TA; Greene NP
    Appl Physiol Nutr Metab; 2022 Sep; 47(9):933-948. PubMed ID: 35700525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype.
    Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E
    J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cachexia Disrupts Diurnal Regulation of Activity, Feeding, and Muscle Mechanistic Target of Rapamycin Complex 1 in Mice.
    Counts BR; Hardee JP; Fix DK; Vanderveen BN; Montalvo RN; Carson JA
    Med Sci Sports Exerc; 2020 Mar; 52(3):577-587. PubMed ID: 32058469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway.
    Shen Q; Kuang JX; Miao CX; Zhang WL; Li YW; Zhang XW; Liu X
    Phytomedicine; 2022 Jan; 95():153858. PubMed ID: 34861585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increase in muscle mitochondrial biogenesis does not prevent muscle loss but increased tumor size in a mouse model of acute cancer-induced cachexia.
    Wang X; Pickrell AM; Zimmers TA; Moraes CT
    PLoS One; 2012; 7(3):e33426. PubMed ID: 22428048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic Alcohol Consumption Enhances Skeletal Muscle Wasting in Mice Bearing Cachectic Cancers: The Role of TNFα/Myostatin Axis.
    Li Y; Zhang F; Modrak S; Little A; Zhang H
    Alcohol Clin Exp Res; 2020 Jan; 44(1):66-77. PubMed ID: 31657476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia.
    Martinelli GB; Olivari D; Re Cecconi AD; Talamini L; Ottoboni L; Lecker SH; Stretch C; Baracos VE; Bathe OF; Resovi A; Giavazzi R; Cervo L; Piccirillo R
    Oncogene; 2016 Dec; 35(48):6212-6222. PubMed ID: 27212031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.